AliveCor presented a number of findings at the 2017 European Society of Cardiology Congress In Barcelona. In addition to the REHEARSE-AF study, they also presented a Cleveland Clinic study and two studies from Hong Kong.
One Hong Kong study, presented by Dr. Bryan Yan of The Chinese University of Hong Kong, looked at more than 12,000 patients aged 65 and older and found that the technology was effective at finding previously undiagnosed AFib. In the other, Dr. Ngai Yin Chan of Princess Margaret Hospital in Hong Kong presented the AFinder Study, wherein community volunteers (non-doctors) performed opportunistic screening for AFib using Kardia Mobile. Out of 10,000 participants aged 50 and older, 244 participants were found to have AFib, with 74 of those previously undiagnosed.
Finally, the iREAD study, presented by the Cleveland Clinic's Dr. Khaldoun Tarakji, looked at the accuracy of AliveCor's automatic AFib algorithm. In 52 patients, the algorithm had a 96.6 percent sensitivity and a 94 percent specificity compared to a cardiologist's assessment of a simultaneous 12-lead EKG.